Skip to main content
INMD
NASDAQ Industrial Applications And Services

InMode Reports Sharp Decline in FY2025 Net Income Amidst Revenue Drop and Ongoing Lawsuit

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$14.61
Mkt Cap
$955.722M
52W Low
$13.14
52W High
$19.78
52W Position info
11% above low
Off High info
26% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

INMD is trading near its 52-week low of $13.14 (11% above the low).

Summary

InMode Ltd. reported a significant decrease in net income and revenue for fiscal year 2025, alongside an update on a shareholder class action lawsuit and heightened geopolitical risk disclosures.


Key Events · Earnings and Guidance · INMD

  • Substantial Profitability Decline

    Net income for fiscal year 2025 fell by 48.2% to $93.8 million from $181.3 million in fiscal year 2024. Operating income also decreased by 24% to $85.4 million.

  • Revenue Contraction

    Total revenue for fiscal year 2025 decreased by 6% to $370.5 million, primarily driven by an 18.9% decline in U.S. sales due to a slowdown in aesthetic procedures and a challenging financing market.

  • Ongoing Shareholder Lawsuit

    The company is actively defending against a shareholder class action lawsuit alleging false or misleading statements, with a motion to dismiss the second amended complaint filed in December 2025.

  • Heightened Geopolitical Risk

    Updated risk factors detail the impact of the Israel-Hamas war and regional escalations, including potential disruptions to operations and employee military service.


Analysis · INMD · Industrial Applications And Services

InMode Ltd.'s annual report reveals a challenging fiscal year 2025, marked by a substantial 48.2% drop in net income and a 6% decline in overall revenue. The significant downturn in U.S. sales, attributed to a slowdown in aesthetic procedures and a difficult financing environment, is a key concern. Investors should note the ongoing shareholder class action lawsuit, which poses a material legal risk, and the detailed geopolitical risk factors related to the Israel-Hamas war and regional instability, which could further impact operations. While new product introductions offer some long-term potential, the immediate financial performance and external risks present a negative outlook for the company.

At the time of this filing, INMD was trading at $14.61 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $955.7M. The 52-week trading range was $13.14 to $19.78. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INMD - Latest Insights

INMD
Jul 20, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $15.36
Real-time Price: $15.17 info
Change: -$0.190 (-1%) info
Market Cap: $871.983M info
INMD
Jul 20, 2026, 7:21 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $15.31
Real-time Price: $15.17 info
Change: -$0.140 (-0.91%) info
Market Cap: $871.983M info
INMD
Jul 16, 2026, 5:51 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $15.50
Real-time Price: $15.17 info
Change: -$0.330 (-2%) info
Market Cap: $871.983M info
INMD
Jul 13, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $15.20
Real-time Price: $15.17 info
Change: -$0.030 (-0.20%) info
Market Cap: $871.983M info
INMD
Jul 13, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $15.20
Real-time Price: $15.17 info
Change: -$0.030 (-0.20%) info
Market Cap: $871.983M info